Anti-CD44 (Bivatuzumab)-MC-MMAF ADC
This ADC product is comprised of an anti-CD44 monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2388-01T1-FITC 100 µL
CD36 (CD36 Antigen, Fatty Acid Translocase, FAT, Glycoprotein IIIb, gpIIIb, gp3b, gpIV, gp4, Leukocyte Differentiation Antigen CD36, PAS-4 Protein, PAS-IV, PASIV, Platelet Collagen Receptor, Platelet Glycoprotein 4, Platelet Glycoprotein IV, Scarb3, Thrombospondin Receptor) (FITC) discontinued
Sign In for Pricing
View Details 
250843-ML550 100 µL
RAD51L3 (RAD51-like 3 (S. cerevisiae), HsTRAD, R51H3, RAD51D, Trad) (MaxLight 550)
Sign In for Pricing
View Details